These results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 support the thought of targeting ACKR3 as a singular approach to modulate the opioid system, which could open new therapeutic avenues for opioid-linked Diseases. Conolidine CONOCB2™ essentially performs by making https://jacks890qne6.popup-blog.com/profile